Urinary minimal residual disease detection predicts recurrence in BCG-unresponsive #NIMBC and quantifies molecular response to nadofaragene firadenovec. Presented by @VikramNarayan@emory_urology. #GU24 written coverage by @zklaassen_md > https://t.co/2SPungsova @ASCO
New data published in the @CCR_AACR journal shows how UroAmp’s diagnostic and prognostic performance compares to standard-of-care procedures like cystoscopy, cytology, and pathology.
#bladdercancer#urology#genomics
https://t.co/yBIQizzXjc
Discover how our genomic urine test, UroAmp, helped validate provider recommendation for radical nephroureterectomy by providing actionable insights that helped confirm suspicion of metachronous UTUC, a rare but aggressive malignancy.
#urology#genomics
https://t.co/oo6AggvmIg
It's #menshealthmonth, an observance that aims to raise awareness of health issues that affect men, like bladder cancer. We stand with you and make it our daily mission to provide better ways to detect, monitor, and personalize bladder cancer care.
#urology#bladdercancer
As #bladdercancermonth23 wraps up; our efforts should not stop here. Let's continue spreading the word so bladder cancer is no longer the "forgotten cancer."
A big shout out to @WorldBladderCan for your efforts in bringing more attention to this disease!
#bladdercanceraware
Why is #bladdercancer considered the "forgotten cancer" despite the significant number of people living with it and its high recurrence rate? Let's come together to increase awareness and fight for those affected by this disease!
#urology#genomics
We innovate in the fight against cancer because standard has never been good enough! To support #BladderCancerMonth23 and patients every day, we've made it our mission to provide a better way to diagnose, monitor, and personalize bladder cancer care.
#bladdercancer#urology
We want to thank #nurses everywhere as you continue providing the highest quality care to your patients. You deserve special recognition for your efforts to excel, lead, and innovate every day!
#NursesWeek2023#ananursesmonth#InternationalNursesDay
At #aua23, we presented some significant findings on how our genomic urine test, UroAmp, can accurately predict bladder cancer up to 12 years before clinical signs and symptoms emerge. Read the press release below.
#Urology#Genomics#bladdercancer
https://t.co/1rqlaNK7Jr
Still at #AUA23? Then stop by our podium presentation to learn how our genomic urine test, UroAmp, can aid in the detection and risk prognosis of upper tract urothelial carcinoma.
#urology#Genomics#bladdercancer
Are you at #AUA23? Then don't forget to stop by our poster presentation to learn how our genomic urine test, UroAmp, can accurately predict bladder cancer up to 12 years before clinical signs and symptoms emerge.
#urology#genomics#bladdercancer#earlydetection
Attending #AUA23? Visit us at booth #2557 to learn how our technology, UroAmp, can help you stay a step ahead of bladder cancer. We look forward to meeting you! #urology#bladdercancer#Genomics
It’s the dedication of our #lab professionals that fuels our vision 2 transform urologic cancer care. Thx Vincent Bicocca, Melissa Vidamo, Jannah Zamora, Nicolai Lumbres, Peter Lentz, Brad Jensen, Lisset Salazar & Martha Evans-Holm 4 your innovations in the fight against #Cancer
We're excited 2 present @ #AUA23 about our genomic urine test's ability to identify upper tract urothelial carcinoma (UTUC) and its accuracy in predicting bladder cancer up to 12 years b4 clinical signs and symptoms emerge. #urology#bladdercancermonth23#Genomics